SCHEMBL29566697

SCHEMBL29566697

COCc1ccccc1-c1cc(Oc2c(C)cccc2Cl)nc(NS(=O)(=O)c2cccc(N)c2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ PIK3C2B O00750 1/20 0.36
▸ PIK3C2G O75747 1/20 0.36
▸ POLB P06746 1/20 0.35
▸ SLC22A12 Q96S37 1/20 0.35
▸ MAPT P10636 1/20 0.34
▸ KDM1A O60341 2/20 0.34
▸ F2 P00734 1/20 0.33
▸ PRSS1 P07477 1/20 0.33
▸ PRSS2 P07478 1/20 0.33
▸ PRSS3 P35030 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309704 1.00 TSHR (0.38) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL24310577 0.90 SMN1; SMN2 (0.40) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL29566688 0.90 SMN1; SMN2 (0.40) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL29566936 0.88 SMN1; SMN2 (0.40) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL24310351 0.88 SMN1; SMN2 (0.40) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL24309706 0.87 LMNA (0.42) MAPTKDM1AKDM4ELMNAMEN1
SCHEMBL29567003 0.86 SMN1; SMN2 (0.36) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL24309272 0.86 SMN1; SMN2 (0.36) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL24309644 0.85 POLB (0.42) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB
SCHEMBL29566684 0.85 POLB (0.42) TSHRSMN1; SMN2PIK3C2BPIK3C2GPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback